Cadila Healthcare informs about press release

13 Sep 2018 Evaluate

Cadila Healthcare has informed about press release titled, 'Zydus receives final approval from the USFDA for Risedronate Sodium Delayed-Release Tablets'.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

883.10 -15.65 (-1.74%)
19-Mar-2026 09:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1760.00
Dr. Reddys Lab 1286.40
Cipla 1258.15
Zydus Lifesciences 883.10
Lupin 2290.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×